Previous studies have indicated that tumors elevate NQO1 to enhance the cell survival and reduction of NQO1 potentially ameliorates the negative effects of tumor-NQO1 overexpression on patient outcome [63]. The gene discussed is NQO1; the disease is neoplasm.